Page 1 | Search Results | Diabetes | American Diabetes Association

1-10 of 10

Sort by

Sort Order Select

Meeting Abstracts

211-OR: Plasma Insulin Is Required for the Increase in Plasma ANGPTL8 Concentration following Glucose Ingestion

MOHAMED ABU-FARHA, JEHAD ABUBAKER, IRINA AL KHAIRI, PREETHI T. CHERIAN, CHRISTINA AGYIN, IV, SIHAM ABDELGANI, EBAA S. ALOZAIRI, JOHN M. ADAMS, II, FAHD ALMULLA, RALPH A. DEFRONZO, MUHAMMAD ABDUL-GHANI

Diabetes 2022;71(Supplement_1):211-OR

https://doi.org/10.2337/db22-211-OR

Published: 01 June 2022

View article titled, 211-OR: Plasma Insulin Is Required for the Increase in Plasma ANGPTL8 Concentration following Glucose Ingestion

Meeting Abstracts

644-P: Effect of PharmacologIC (EPIC) Therapy on Insulin Sensitivity and Beta-Cell Function in Prediabetes (PreDM)

ALBERTO O. CHAVEZ VELAZQUEZ, EMAD ALI, AURORA MEROVCI, CHRISTINA AGYIN, IV, TOMOKO TERASAWA, MUHAMMAD ABDUL-GHANI, CURTIS L. TRIPLITT, EUGENIO CERSOSIMO, RALPH A. DEFRONZO

Diabetes 2022;71(Supplement_1):644-P

https://doi.org/10.2337/db22-644-P

Published: 01 June 2022

View article titled, 644-P: Effect of PharmacologIC (EPIC) Therapy on Insulin Sensitivity and Beta-Cell Function in Prediabetes (PreDM)

Meeting Abstracts

756-P: Bromocriptine-QR (BQR) Ameliorates Immunocyte Pro-Oxidative Stress/Proinflammatory (POS/PI) and ER Stress Phenotype in T2DM Subjects

MICHAEL EZROKHI, ANTHONY H. CINCOTTA, EUGENIO CERSOSIMO, JOHN M. ADAMS, II, MARIAM ALATRACH, CHRISTINA AGYIN, IV, CURTIS L. TRIPLITT, NICHOLAS COMINOS, RALPH A. DEFRONZO

Diabetes 2021;70(Supplement_1):756-P

https://doi.org/10.2337/db21-756-P

Published: 01 June 2021

View article titled, 756-P: Bromocriptine-QR (BQR) Ameliorates Immunocyte Pro-Oxidative Stress/Proinflammatory (POS/PI) and ER Stress Phenotype in T2DM Subjects

Meeting Abstracts

352-OR: Combination Therapy with Dapagliflozin plus Exenatide on Endogenous Glucose Production: A Mechanism of Action Study

MARIAM ALATRACH, CHRISTINA AGYIN, IV, JOHN M. ADAMS, II, OLGA LAVRYNENKO, NITCHAKARN LAICHUTHAI, EUGENIO CERSOSIMO, CURTIS L. TRIPLITT, AMALIA GASTALDELLI, MUHAMMAD ABDUL-GHANI, RALPH A. DEFRONZO

Diabetes 2020;69(Supplement_1):352-OR

https://doi.org/10.2337/db20-352-OR

Published: 01 June 2020

View article titled, 352-OR: Combination Therapy with Dapagliflozin plus Exenatide on Endogenous Glucose Production: A Mechanism of Action Study

Meeting Abstracts

1136-P: Glucose Kinetics during Oral Glucose Challenge following Administration of Exenatide and Dapagliflozin Alone and in Combination in Type 2 Diabetes

MARIAM ALATRACH, CHRISTINA AGYIN, IV, NITCHAKARN LAICHUTHAI, OLGA LAVRYNENKO, JOHN M. ADAMS, II, MUHAMMAD ABDUL-GHANI, CURTIS L. TRIPLITT, RALPH A. DEFRONZO, EUGENIO CERSOSIMO

Diabetes 2020;69(Supplement_1):1136-P

https://doi.org/10.2337/db20-1136-P

Published: 01 June 2020

View article titled, 1136-P: Glucose Kinetics during Oral Glucose Challenge following Administration of Exenatide and Dapagliflozin Alone and in Combination in Type 2 Diabetes

Meeting Abstracts

1070-P: Bromocriptine-QR (BQR) Ameliorates a Pro-oxidative Stress/Proinflammatory (POS/PI) Monocyte Phenotype in Poorly Controlled T2DM Subjects

MICHAEL EZROKHI, ANTHONY CINCOTTA, EUGENIO CERSOSIMO, JOHN M. ADAMS, II, MARIAM ALATRACH, CHRISTINA AGYIN, IV, CURTIS L. TRIPLITT, NICHOLAS COMINOS, RALPH A. DEFRONZO

Diabetes 2020;69(Supplement_1):1070-P

https://doi.org/10.2337/db20-1070-P

Published: 01 June 2020

View article titled, 1070-P: Bromocriptine-QR (BQR) Ameliorates a Pro-oxidative Stress/Proinflammatory (POS/PI) Monocyte Phenotype in Poorly Controlled T2DM Subjects

Journal Articles

Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors

Mariam Alatrach, Nitchakarn Laichuthai, Robert Martinez, Christina Agyin, Ali Muhammed Ali, Hussein Al-Jobori, Olga Lavynenko, John Adams, Curtis Triplitt, Ralph DeFronzo, Eugenio Cersosimo, Muhammad Abdul-Ghani

Diabetes 2020;69(4):681–688

https://doi.org/10.2337/db19-0770

Published: 08 January 2020

View article titled, Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors

Includes: Supplementary data

Meeting Abstracts

246-OR: Contribution of Plasma Glucose and Hormones to the Acute Compensatory Rise in Endogenous Glucose Production (EGP) during Glucosuria in T2D Patients

MARIAM ALATRACH, CHRISTINA AGYIN, IV, NITCHAKARN LAICHUTHAI, JOHN M. ADAMS, II, MUHAMMAD ABDUL-GHANI, CURTIS L. TRIPLITT, RALPH A. DEFRONZO, EUGENIO CERSOSIMO

Diabetes 2019;68(Supplement_1):246-OR

https://doi.org/10.2337/db19-246-OR

Published: 01 June 2019

View article titled, 246-OR: Contribution of Plasma Glucose and Hormones to the Acute Compensatory Rise in Endogenous Glucose Production (EGP) during Glucosuria in T2D Patients

Meeting Abstracts

1166-P: Bromocriptine-QR (BQR) Therapy Reduces Elevated Sympathetic Nervous System Activity (SNSA) and Oxidative Stress (OS) in Type 2 Diabetes (T2D) Subjects whose Dysglycemia Is Poorly Controlled on GLP-1 Receptor Agonist (GLP-1RA)

BINDU CHAMARTHI, EUGENIO CERSOSIMO, JOHN M. ADAMS, II, MARIAM ALATRACH, CHRISTINA AGYIN, CURTIS L. TRIPLITT, MICHAEL EZROKHI, SHUQIN LUO, EMILIE DUVALLET, ANTHONY H. CINCOTTA, RALPH A. DEFRONZO

Diabetes 2019;68(Supplement_1):1166-P

https://doi.org/10.2337/db19-1166-P

Published: 01 June 2019

View article titled, 1166-P: Bromocriptine-QR (BQR) Therapy Reduces Elevated Sympathetic Nervous System Activity (SNSA) and Oxidative Stress (OS) in Type 2 Diabetes (T2D) Subjects whose Dysglycemia Is Poorly Controlled on GLP-1 Receptor Agonist (GLP-1RA)

Meeting Abstracts

155-LB: The Increase in Endogenous Glucose Production with SGLT2 Inhibition Is Unchanged by Renal Denervation but Highly Correlates to Urinary Glucose Excretion

CAROLINA SOLIS-HERRERA, MARIAM ALATRACH, CHRISTINA AGYIN, HENRI HONKA, RUPAL PATEL, CURTIS L. TRIPLITT, JOHN M. ADAMS, II, AMALIA GASTALDELLI, MUHAMMAD ABDUL-GHANI, EUGENIO CERSOSIMO, RALPH A. DEFRONZO

Diabetes 2019;68(Supplement_1):155-LB

https://doi.org/10.2337/db19-155-LB

Published: 01 June 2019

View article titled, 155-LB: The Increase in Endogenous Glucose Production with SGLT2 Inhibition Is Unchanged by Renal Denervation but Highly Correlates to Urinary Glucose Excretion

NARROW

211-OR: Plasma Insulin Is Required for the Increase in Plasma ANGPTL8 Concentration following Glucose Ingestion

644-P: Effect of PharmacologIC (EPIC) Therapy on Insulin Sensitivity and Beta-Cell Function in Prediabetes (PreDM)

756-P: Bromocriptine-QR (BQR) Ameliorates Immunocyte Pro-Oxidative Stress/Proinflammatory (POS/PI) and ER Stress Phenotype in T2DM Subjects

352-OR: Combination Therapy with Dapagliflozin plus Exenatide on Endogenous Glucose Production: A Mechanism of Action Study

1136-P: Glucose Kinetics during Oral Glucose Challenge following Administration of Exenatide and Dapagliflozin Alone and in Combination in Type 2 Diabetes

1070-P: Bromocriptine-QR (BQR) Ameliorates a Pro-oxidative Stress/Proinflammatory (POS/PI) Monocyte Phenotype in Poorly Controlled T2DM Subjects

Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors

246-OR: Contribution of Plasma Glucose and Hormones to the Acute Compensatory Rise in Endogenous Glucose Production (EGP) during Glucosuria in T2D Patients

1166-P: Bromocriptine-QR (BQR) Therapy Reduces Elevated Sympathetic Nervous System Activity (SNSA) and Oxidative Stress (OS) in Type 2 Diabetes (T2D) Subjects whose Dysglycemia Is Poorly Controlled on GLP-1 Receptor Agonist (GLP-1RA)

155-LB: The Increase in Endogenous Glucose Production with SGLT2 Inhibition Is Unchanged by Renal Denervation but Highly Correlates to Urinary Glucose Excretion

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only